Companies › ACRV

ACRIVON THERAPEUTICS INC (ACRV)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001781174 · EDGAR filings · Updated 2026-07-23

ACRIVON THERAPEUTICS INC (ACRV) has reported institutional ownership of 41.9%, with 44 institutional managers holding positions valued at $22.6M per the latest 13F reporting period.

Filings this week (1)

• 2026-07-23 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-22 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ACRIVON THERAPEUTICS INC has 44 institutional holders and institutional ownership of 41.9%.

Insider activity

Insiders reported 42 transactions (3 buys, 5 sells) across 8 reporting insiders, with a net reported value of −$3.65M.

Related companies

FILANA THERAPEUTICS INC (FLNA) · NEXTCURE INC (NXTC) · Black Hawk Acquisition Corp (BKHA) · ALPHA TEKNOVA INC (TKNO) · Aligos Therapeutics Inc (ALGS) · BIOTE CORP (BTMD)